Profound Medical Corp.
General ticker "PROF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $145.1M (TTM average)
Profound Medical Corp. follows the US Stock Market performance with the rate: 42.5%.
Estimated limits based on current volatility of 3.3%: low 6.20$, high 6.61$
Factors to consider:
- Total employees count: 87 as of 2024
- US accounted for 60.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Limited operating history, High capital intensity, Market acceptance, Reimbursement risks, Partner dependency
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.94$, 11.29$]
- 2026-12-31 to 2027-12-31 estimated range: [4.57$, 10.55$]
Financial Metrics affecting the PROF estimates:
- Positive: with PPE of -5.3 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -23.43 <= 0.07
- Positive: Investing cash flow per share per price, % of -0.15 > -0.65
- Negative: negative Net income
- Positive: 42.60 < Shareholder equity ratio, % of 47.16 <= 64.25
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term PROF quotes
Long-term PROF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.20MM | $10.68MM | $16.38MM |
| Operating Expenses | $35.85MM | $43.74MM | $58.36MM |
| Operating Income | $-28.65MM | $-33.06MM | $-41.98MM |
| Non-Operating Income | $0.20MM | $5.24MM | $-1.08MM |
| R&D Expense | $14.42MM | $16.96MM | $20.60MM |
| Income(Loss) | $-28.45MM | $-27.82MM | $-43.06MM |
| Taxes | $-0.13MM | $-0.00MM | $0.26MM |
| Profit(Loss)* | $-28.57MM | $-26.48MM | $42.32MM |
| Stockholders Equity | $31.22MM | $60.42MM | $90.99MM |
| Inventory | $6.99MM | $5.80MM | $11.28MM |
| Assets | $43.96MM | $70.23MM | $192.94MM |
| Operating Cash Flow | $-22.61MM | $-23.45MM | $-53.34MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.25MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.34MM |
| Financing Cash Flow | $1.76MM | $54.70MM | $57.43MM |
| Earnings Per Share** | $-1.35 | $-1.07 | $1.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.